TRACP-5b

There are 19 papers on TRACP-5b in aging research: 1 trial and 8 observational studies in people, 8 in animals, 2 reviews. The newest story, Oct 30, 2026: “Knee osteoarthritis linked to higher osteoporosis risk”.

Biomarker

19 papers study it14 more mention it7 findings

1 new paper in 30 daysSee all 33 papers on TRACP-5b

“there was a significant independent association between low BMD and TRACP-5b in females”
Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registryScientific reports2021doi:10.1038/s41598-021-87393-7
  • Human trial1
  • Humans8
  • Animals8

Interventions

3

Romosozumab

downin humans1

1 study
  1. Romosozumab is linked with lower TRACP-5b in humans (osteoporosis) (-32.1% vs. -33.1%).

    “TRACP-5b - 32.1% vs. - 33.1%, P = 0.746”

    Humansosteoporosissubcutaneous210 mg monthly12 months

    Equivalent Twelve-Month Bone Mineral Density Response to Romosozumab in Patients Aged ≥ 85 Years and < 85 Years: A Multi-center Real-World Cohort Study (n = 417) from Northern Japan

    Calcified tissue international

More on Romosozumab

Surgical menopause

upin humans1

1 study
  1. Surgical menopause is linked with higher TRACP-5b in humans.

    “TRACP-5b and urinary pentosidine levels significantly increased 6 months postoperatively compared with preoperative levels.”

    Humans6 monthsfemalesn = 50

    Pilot study of the effect of surgical menopause on bone mineral density and quality in patients with gynecological malignancies

    The journal of obstetrics and gynaecology research

More on Surgical menopause

Citrus tamurana

downin humans1

1 study
  1. Citrus tamurana decreases TRACP-5b in humans (postmenopausal women) (310.0 [269.2-350.9] vs. 386.4 [341.2-431.6] mU/dL).

    “the study group had significantly lower TRACP5b and P1NP levels at day 90 than the control group (mean [95% confidence interval]; TRACP5b: 310.0 [269.2-350.9] vs. 386.4 [341.2-431.6] mU/dL”

    Human trialpostmenopausal womenarabinogalactan-rich juiceblood90 daysfemalesn = 63

    Citrus tamurana Hort. ex Tanaka (Hyuganatsu orange)-derived arabinogalactan suppresses bone turnover in postmenopausal women: A randomized placebo-controlled study

    The journal of obstetrics and gynaecology research

More on Citrus tamurana

Associations

4

Sarcopenia

upin humans1OR 1.05

1 study
  1. TRACP-5b is linked with a higher risk of sarcopenia in humans (adjusted for confounders) (OR 1.05, 95% CI 1.01-1.10).

    “TRACP-5b (odds ratio 1.05, 95% confidence interval 1.01-1.10) and femoral neck BMD (odds ratio 0.30, 95% confidence interval 0.14-0.68) were associated with the presence of sarcopenia”

    Humansadjusted for confounders

    Relationship Between Bone Metabolic Markers and Presence of Sarcopenia in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

    Journal of clinical medicine

More on Sarcopenia

Low bone mineral density

mixedin humans1

1 study
  1. TRACP-5b is associated with low bone mineral density in humans.

    “there was a significant independent association between low BMD and TRACP-5b in females”

    Humansfemales

    Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry

    Scientific reports

More on Low bone mineral density

Low cortical bone thickness

upin humans1

1 study
  1. Low cortical bone thickness is associated with TRACP-5b in humans.

    “The percentage of diabetic participants, TRACP-5b, and myostatin levels were significantly higher”

    Humans

    Evaluation of myostatin as a possible regulator and marker of skeletal muscle-cortical bone interaction in adults

    Journal of bone and mineral metabolism

Osteocalcin

mixedin humans1

1 study
  1. Osteocalcin is associated with TRACP-5b in humans.

    “was significantly associated with TRACP-5b levels and age”

    Humansn = 254

    Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study

    BMC musculoskeletal disorders

More on Osteocalcin

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 3Sep 2026: 4Oct 2026: 2Nov 2026: 014 papers in 12 months
Frontiers in Public Health

Knee osteoarthritis linked to higher osteoporosis risk

Osteoporosis developed in 5.2% of participants with knee osteoarthritis versus 3.9% without it over a median 10 years of follow-up.Osteoporosis developed in 5.2% of participants with knee osteoarthritis versus 3.9% without it over a median 10 years of follow-up.

Cohort · 406,810 peopleKnee osteoarthritis

See all 33 papers on TRACP-5b